Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karthick Mayilsamy

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 30, 2020
Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injuryKarthick Mayilsamy, Eleni Markoutsa, Mahasweta Das, et al.
Molecular Therapy. Methods & Clinical Development|October 3, 2022
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease riskRyan Green, Karthick Mayilsamy, Andrew R McGill, et al.
Viruses|March 26, 2022
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced InfectivityAhmed A Ramadan, Karthick Mayilsamy, Andrew R McGill, et al.
PNAS Nexus|January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 30, 2020
Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injuryKarthick Mayilsamy, Eleni Markoutsa, Mahasweta Das, et al.
Molecular Therapy. Methods & Clinical Development|October 3, 2022
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease riskRyan Green, Karthick Mayilsamy, Andrew R McGill, et al.
Viruses|March 26, 2022
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced InfectivityAhmed A Ramadan, Karthick Mayilsamy, Andrew R McGill, et al.
PNAS Nexus|January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Pageof 2